Literature DB >> 5898685

[Separation, isolation and identification of metabolic products of triamterene].

K Lehmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5898685

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  9 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Dissociation of the natriuretic and antikaliuretic properties of triamterene derivatives by dose-response experiments.

Authors:  H Priewer; E Wolf; H Kraft; H Knauf; E Mutschler
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

3.  Plasma and urinary levels of triamterene and certain metabolites after oral administration to man.

Authors:  U Gundert-Remy; D von Kenne; E Weber; H E Geissler; B Grebian; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

4.  Sulphate conjugation of p-hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

Authors:  C Reiter; P G Werness; J Van Loon; L H Smith; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

5.  Pharmacokinetic and pharmacodynamic study of the combination of furosemide retard and triamterene.

Authors:  D Loew; D Barkow; O Schuster; H E Knoell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  [Pharmacokinetics of triamterene in healthy subjects and patients with liver and kidney function disorders].

Authors:  E Mutschler; H J Gilfrich; H Knauf; W Möhrke; K D Völger
Journal:  Klin Wochenschr       Date:  1983-09-15

7.  Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.

Authors:  H J Gilfrich; G Kremer; W Möhrke; E Mutschler; K D Völger
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

9.  Delayed elimination of triamterene and its active metabolite in chronic renal failure.

Authors:  H Knauf; W Möhrke; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.